Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2007

01-04-2007 | Original Paper

Screening for Celiac Disease in Family Members: Is Follow-up Testing Necessary?

Authors: David Goldberg, Debbie Kryszak, Alessio Fasano, Peter H. R. Green

Published in: Digestive Diseases and Sciences | Issue 4/2007

Login to get access

Abstract

Celiac disease is a genetically determined intolerance to gluten that results in villous atrophy in the small intestine. Because celiac disease occurs in families, relatives of affected individuals are tested for the disease. However, there are no evidence-based guidelines for when, or how often, to test relatives. Our goal was to determine if one-time screening of relatives is sufficient. Of 171 family members with an initially negative endomysial antibody who were tested on more than one occasion, 6 (3.5%) were positive on repeat testing. The average time to seroconversion was 1.7±1.2 years (range, 6 months–3 years 2 months). Only one of the seroconverters had diarrhea; the remainder were asymptomatic. None of the patients had a change in symptoms between testing. We conclude that one-time testing for celiac disease among families with affected members is insufficient. Repeat testing should occur irrespective of the presence of symptoms.
Literature
1.
go back to reference James SP (2005) National Institutes of Health consensus development conference statement on celiac disease, June 28–30, 2004. Gastroenterology 128:S1–S9CrossRef James SP (2005) National Institutes of Health consensus development conference statement on celiac disease, June 28–30, 2004. Gastroenterology 128:S1–S9CrossRef
3.
go back to reference Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventrua A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163:286–292PubMedCrossRef Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventrua A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163:286–292PubMedCrossRef
4.
go back to reference Lo W, Sano K, Lebwohl B, Diamond B, Green PH (2003) Changing presentation of adult celiac disease. Dig Dis Sci 48:395–398PubMedCrossRef Lo W, Sano K, Lebwohl B, Diamond B, Green PH (2003) Changing presentation of adult celiac disease. Dig Dis Sci 48:395–398PubMedCrossRef
5.
go back to reference Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T (2000) Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 95:1253–1257PubMedCrossRef Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T (2000) Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 95:1253–1257PubMedCrossRef
6.
go back to reference Verhulst ML, Dur AH, Driessen WM (1993) Two sisters with coeliac disease and jejunal cancer: just a coincidence? Neth J Med 42:16–20PubMed Verhulst ML, Dur AH, Driessen WM (1993) Two sisters with coeliac disease and jejunal cancer: just a coincidence? Neth J Med 42:16–20PubMed
7.
go back to reference Vitoria JC, Arrieta A, Astigarraga I, Garcia-Masdevall D, Rodriguez-Soriano J (1994) Use of serological markers as a screening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr 19:304–309PubMedCrossRef Vitoria JC, Arrieta A, Astigarraga I, Garcia-Masdevall D, Rodriguez-Soriano J (1994) Use of serological markers as a screening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr 19:304–309PubMedCrossRef
8.
go back to reference Niveloni S, Pedreira S, Sugai E, Vazquez H, Smecuol E, Fiorini A, Cabanne A, Dezi R, Valero J, Kogan Z, Maurino E, Bai JC (2000) The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives. Am J Gastroenterol 95:463–468PubMedCrossRef Niveloni S, Pedreira S, Sugai E, Vazquez H, Smecuol E, Fiorini A, Cabanne A, Dezi R, Valero J, Kogan Z, Maurino E, Bai JC (2000) The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives. Am J Gastroenterol 95:463–468PubMedCrossRef
9.
go back to reference Rostami K, Mulder CJ, van Overbeek FM, Kerckhaert J, Meijer JW, von Blomberg MB, Heymans HS (2000) Should relatives of coeliacs with mild clinical complaints undergo a small-bowel biopsy despite negative serology? Eur J Gastroenterol Hepatol 12:51–55PubMedCrossRef Rostami K, Mulder CJ, van Overbeek FM, Kerckhaert J, Meijer JW, von Blomberg MB, Heymans HS (2000) Should relatives of coeliacs with mild clinical complaints undergo a small-bowel biopsy despite negative serology? Eur J Gastroenterol Hepatol 12:51–55PubMedCrossRef
10.
go back to reference Pittschieler K, Gentili L, Niederhofer H (2003) Onset of coeliac disease: a prospective longitudinal study. Acta Paediatr 92:1149–1152PubMedCrossRef Pittschieler K, Gentili L, Niederhofer H (2003) Onset of coeliac disease: a prospective longitudinal study. Acta Paediatr 92:1149–1152PubMedCrossRef
11.
go back to reference Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L (2003) Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 38:61–65PubMedCrossRef Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L (2003) Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 38:61–65PubMedCrossRef
12.
go back to reference Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D (2004) The prevalence of celiac disease among family members of celiac disease patients. Wien Klin Wochenschr 116(Suppl 2):8–12PubMed Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D (2004) The prevalence of celiac disease among family members of celiac disease patients. Wien Klin Wochenschr 116(Suppl 2):8–12PubMed
13.
go back to reference Murray JA (2005) Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis? Gastroenterology 128:S52–S56PubMedCrossRef Murray JA (2005) Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis? Gastroenterology 128:S52–S56PubMedCrossRef
14.
go back to reference Vazquez H, Sugai E, Pedreira S, Katz S, Litwin N, De Rosa S, Ruiz J, Soifer G, Kogan Z, Boerr L (1995) Screening for asymptomatic celiac sprue in families. J Clin Gastroenterol 21:130–133PubMedCrossRef Vazquez H, Sugai E, Pedreira S, Katz S, Litwin N, De Rosa S, Ruiz J, Soifer G, Kogan Z, Boerr L (1995) Screening for asymptomatic celiac sprue in families. J Clin Gastroenterol 21:130–133PubMedCrossRef
15.
go back to reference Szaflarska-Szczepanik A, Czerwionka-Szaflarska M (2001) The frequency of occurrence and clinical picture of celiac disease in the parents of children with the disease. Med Sci Monit 7:971–976PubMed Szaflarska-Szczepanik A, Czerwionka-Szaflarska M (2001) The frequency of occurrence and clinical picture of celiac disease in the parents of children with the disease. Med Sci Monit 7:971–976PubMed
16.
go back to reference Farre C, Humbert P, Vilar P, Varea V, Aldeguer X, Carnicer J, Carballo M, Gassull MA (1999) Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Dig Dis Sci 44:2344–2349PubMedCrossRef Farre C, Humbert P, Vilar P, Varea V, Aldeguer X, Carnicer J, Carballo M, Gassull MA (1999) Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Dig Dis Sci 44:2344–2349PubMedCrossRef
17.
go back to reference Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RP, Picarelli A, Magliocca FM, Mora B, Bardella MT, Verrienti A, Fiore B, Uccini S, Megiorni F, Mazzilli MC, Tiberti C (2006) Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 42:150–154PubMedCrossRef Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RP, Picarelli A, Magliocca FM, Mora B, Bardella MT, Verrienti A, Fiore B, Uccini S, Megiorni F, Mazzilli MC, Tiberti C (2006) Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 42:150–154PubMedCrossRef
18.
go back to reference Book L, Zone JJ, Neuhausen SL (2003) Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 98:377–381PubMedCrossRef Book L, Zone JJ, Neuhausen SL (2003) Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 98:377–381PubMedCrossRef
19.
go back to reference Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA (2002) The first large population based twin study of coeliac disease. Gut 50:624–628PubMedCrossRef Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA (2002) The first large population based twin study of coeliac disease. Gut 50:624–628PubMedCrossRef
20.
go back to reference Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M (1996) Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 41:83–87PubMedCrossRef Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M (1996) Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 41:83–87PubMedCrossRef
21.
go back to reference Fasano A, Catassi C (2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636–651PubMedCrossRef Fasano A, Catassi C (2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636–651PubMedCrossRef
22.
go back to reference Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128:S38–S46PubMedCrossRef Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128:S38–S46PubMedCrossRef
23.
go back to reference Abrams J, Diamond B, Rotterdam H, Green PH (2004) Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 49:546–550PubMedCrossRef Abrams J, Diamond B, Rotterdam H, Green PH (2004) Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 49:546–550PubMedCrossRef
24.
go back to reference Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ (1999) Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94:888–894PubMedCrossRef Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ (1999) Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94:888–894PubMedCrossRef
25.
go back to reference Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H (2001) Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies. J Pediatr Gastroenterol Nutr 33:276–282PubMedCrossRef Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H (2001) Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies. J Pediatr Gastroenterol Nutr 33:276–282PubMedCrossRef
26.
go back to reference Dickey W, Hughes DF, McMillan SA (2000) Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 35:181–183PubMedCrossRef Dickey W, Hughes DF, McMillan SA (2000) Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 35:181–183PubMedCrossRef
27.
go back to reference Tursi A, Brandimarte G, Giorgetti GM, Inchingolo CD (2003) Effectiveness of the sorbitol H2 breath test in detecting histological damage among relatives of coeliacs. Scand J Gastroenterol 38:727–731PubMedCrossRef Tursi A, Brandimarte G, Giorgetti GM, Inchingolo CD (2003) Effectiveness of the sorbitol H2 breath test in detecting histological damage among relatives of coeliacs. Scand J Gastroenterol 38:727–731PubMedCrossRef
28.
go back to reference Smecuol E, Vazquez H, Sugai E, Niveloni S, Pedreira S, Cabanne A, Fiorini A, Kogan Z, Maurino E, Meddings J, Bai JC (1999) Sugar tests detect celiac disease among first-degree relatives. Am J Gastroenterol 94:3547–3552PubMedCrossRef Smecuol E, Vazquez H, Sugai E, Niveloni S, Pedreira S, Cabanne A, Fiorini A, Kogan Z, Maurino E, Meddings J, Bai JC (1999) Sugar tests detect celiac disease among first-degree relatives. Am J Gastroenterol 94:3547–3552PubMedCrossRef
29.
go back to reference Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128:S38–S46PubMedCrossRef Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128:S38–S46PubMedCrossRef
Metadata
Title
Screening for Celiac Disease in Family Members: Is Follow-up Testing Necessary?
Authors
David Goldberg
Debbie Kryszak
Alessio Fasano
Peter H. R. Green
Publication date
01-04-2007
Published in
Digestive Diseases and Sciences / Issue 4/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9518-1

Other articles of this Issue 4/2007

Digestive Diseases and Sciences 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine